Santhera Pharmaceuticals (SPHDF) Short Interest Ratio & Short Volume $9.42 0.00 (0.00%) (As of 12/20/2024 ET) Add Compare Share Share Short Interest Stock AnalysisChartHeadlinesShort Interest Santhera Pharmaceuticals Short Interest DataSanthera Pharmaceuticals (SPHDF) has a short interest of 100 shares. This marks a 0.00% change in short interest from the previous month. The short interest ratio (days to cover) is 0.0, indicating that it would take 0.0 days of the average trading volume of 400 shares to cover all short positions.Current Short Interest100 sharesPrevious Short Interest100 sharesChange Vs. Previous MonthNo ChangeDollar Volume Sold Short$1,170.00Short Interest Ratio0.0 Days to CoverLast Record DateNovember 30, 2024Today's Trading Volume890 sharesAverage Trading Volume400 sharesToday's Volume Vs. Average223% Short Selling Santhera Pharmaceuticals? Sign up to receive the latest short interest report for Santhera Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartSPHDF Short Interest Over TimeSPHDF Days to Cover Over TimeSPHDF Percentage of Float Shorted Over Time Ad Crypto 101 MediaTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… YES, I WANT THE #1 CRYPTO NOW Santhera Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 11/30/2024100 shares $1,170.00 No ChangeN/A0 $11.70 11/15/2024100 shares $1,170.00 No ChangeN/A0 $11.70 10/31/2024100 shares $1,170.00 No ChangeN/A0 $11.70 10/15/2024100 shares $1,170.00 No ChangeN/A0 $11.70 9/30/2024100 shares $1,170.00 No ChangeN/A0 $11.70 9/15/2024100 shares $1,170.00 No ChangeN/A1 $11.70 Get the Latest News and Ratings for SPHDF and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Santhera Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 8/31/2024100 shares $1,170.00 -99.9%N/A0 $11.70 8/15/202479,900 shares $934,830.00 No ChangeN/A0 $11.70 7/31/202479,900 shares $934,830.00 No ChangeN/A0 $11.70 7/15/202479,900 shares $934,830.00 -3.6%N/A799 $11.70 6/30/202482,900 shares $969,930.00 +3.8%N/A0 $11.70 6/15/202479,900 shares $934,830.00 No ChangeN/A0 $11.70 5/31/202479,900 shares $934,830.00 -2.3%N/A0 $11.70 5/15/202481,800 shares $957,060.00 -5.9%N/A818 $11.70 4/30/202486,900 shares $1.02 million +8.1%N/A0 $11.70 4/15/202480,400 shares $940,680.00 -2.1%N/A160.8 $11.70 3/31/202482,100 shares $960,570.00 +1.4%N/A0 $11.70 3/15/202481,000 shares $947,700.00 +1.4%N/A0 $11.70 2/29/202479,900 shares $934,830.00 -5.2%N/A799 $11.70 2/15/202484,300 shares $948,375.00 -0.8%N/A843 $11.25 1/15/202483,700 shares $979,290.00 -5.0%N/A0 $11.70 12/31/202388,100 shares $1.03 million -8.1%N/A28.9 $11.70 12/15/202395,900 shares $1.12 million -6.4%N/A239.8 $11.70 11/30/2023102,500 shares $1.37 million -19.4%N/A0 $13.35 11/15/2023127,200 shares $1.70 million -6.7%N/A0 $13.35 10/31/2023136,400 shares $1.82 million +69.0%N/A104.9 $13.35 10/15/202380,700 shares $758,580.00 No ChangeN/A403.5 $9.40 9/30/202380,700 shares $54,876.00 -2.3%N/A403.5 $0.68 9/15/202382,600 shares $850,119.20 -0.2%N/A0 $10.29 8/31/202382,800 shares $56,304.00 -27.6%N/A10353.9 $0.68 8/15/2023114,300 shares $77,724.00 No ChangeN/A0 $0.68 6/30/20231,143,400 shares $7.78 million +254.3%N/A357.3 $6.80 6/15/2023322,700 shares $219,436.00 -7.4%N/A0 $0.68 5/31/2023348,500 shares $236,980.00 +20.5%N/A0 $0.68 5/15/2023289,200 shares $196,656.00 +18.5%N/A0 $0.68 4/30/2023244,000 shares $165,920.00 +0.1%N/A406.7 $0.68 4/15/2023243,800 shares $165,784.00 -3.1%N/A348.3 $0.68 3/31/2023251,700 shares $302,040.00 -28.4%N/A0 $1.20 3/15/2023351,500 shares $421,800.00 -0.7%N/A0 $1.20 2/28/2023354,000 shares $424,800.00 -10.1%N/A0 $1.20Trump’s Sending THIS Crypto Higher on Purpose (Ad)Discover the coin set to explode before 2025! Trump could trigger THIS crypto coin… YES, I WANT THE #1 CRYPTO NOW 2/15/2023393,700 shares $472,440.00 -1.9%N/A0 $1.20 1/31/2023401,500 shares $481,800.00 -1.6%N/A0 $1.20 1/15/2023407,900 shares $489,480.00 -27.8%N/A4079 $1.20 12/30/2022564,900 shares $796,509.00 +328.9%N/A282.5 $1.41 12/15/2022131,700 shares $185,697.00 +0.8%N/A0 $1.41 11/30/2022130,700 shares $184,287.00 No ChangeN/A0 $1.41 11/15/2022130,700 shares $184,287.00 No ChangeN/A0 $1.41 10/31/2022130,700 shares $184,287.00 No ChangeN/A0 $1.41 10/15/2022130,700 shares $184,287.00 +312.3%N/A130.7 $1.41 9/30/202231,700 shares $44,697.00 -97.0%N/A0 $1.41 9/15/20221,062,900 shares $1.50 million +8.1%N/A265.7 $1.41 8/31/2022983,000 shares $1.39 million +6.5%N/A0 $1.41 8/15/2022923,300 shares $1.30 million +4.5%N/A0 $1.41 7/31/2022883,700 shares $1.25 million -0.1%N/A0 $1.41 7/15/2022884,900 shares $1.25 million +0.1%N/A0 $1.41 6/30/2022883,700 shares $1.25 million No ChangeN/A0 $1.41 6/15/2022883,700 shares $1.25 million +0.1%N/A0 $1.41 5/31/2022882,700 shares $1.24 million -6.0%N/A0 $1.41 5/15/2022938,600 shares $1.32 million +2.4%N/A0 $1.41 4/30/2022916,500 shares $1.29 million +1.1%N/A0 $1.41 4/15/2022906,300 shares $1.28 million -5.5%N/A0 $1.41 3/31/2022959,500 shares $1.35 million +11.7%N/A0 $1.41 3/15/2022859,200 shares $1.21 million -10.6%N/A0 $1.41 2/28/2022960,700 shares $1.35 million +13.4%N/A0 $1.41 2/15/2022847,300 shares $1.19 million -0.6%N/A0 $1.41 1/31/2022852,800 shares $1.20 million +1.4%N/A0 $1.41 1/15/2022841,200 shares $1.19 million +6.3%N/A0 $1.41 12/31/2021791,300 shares $1.12 million -0.5%N/A3956.5 $1.41 12/15/2021794,900 shares $1.11 million -2.9%N/A0 $1.40 11/30/2021818,500 shares $1.15 million +4.5%N/A125.9 $1.40 11/15/2021783,100 shares $1.07 million +6.0%N/A195.8 $1.37 10/29/2021738,800 shares $1.03 million +0.2%N/A7388 $1.40 10/15/2021737,300 shares $1.13 million -1.5%N/A491.5 $1.53 9/30/2021748,800 shares $1.18 million +4.0%N/A832 $1.58 9/15/2021720,000 shares $1.61 million +30.6%N/A720 $2.23 8/31/2021551,200 shares $1.38 million +8.5%N/A212 $2.50 8/13/2021507,900 shares $1.16 million -1.1%N/A84.7 $2.28 7/30/2021513,500 shares $1.28 million +7.0%N/A88.5 $2.50 7/15/2021479,800 shares $1.28 million +9.4%N/A154.8 $2.67 6/30/2021438,400 shares $1.32 million +11.2%N/A438.4 $3.00 6/15/2021394,300 shares $1.12 million +1.2%N/A34.3 $2.85 5/28/2021389,800 shares $955,010.00 +11.8%N/A18.4 $2.45 5/14/2021348,700 shares $958,925.00 +19.5%N/A166 $2.75 4/30/2021291,800 shares $854,974.00 -9.5%N/A1459 $2.93 4/15/2021322,500 shares $983,625.00 -0.2%N/A3225 $3.05 3/31/2021323,100 shares $1.03 million +5.4%N/A190.1 $3.20 3/15/2021306,600 shares $1.01 million +0.8%N/A340.7 $3.30 2/26/2021304,200 shares $1.09 million +9.5%N/A144.9 $3.58 2/12/2021277,800 shares $1.47 million +10.8%N/A99.2 $5.29 1/29/2021250,700 shares $839,845.00 -0.4%N/A192.8 $3.35Trump’s Sending THIS Crypto Higher on Purpose (Ad)Discover the coin set to explode before 2025! Trump could trigger THIS crypto coin… YES, I WANT THE #1 CRYPTO NOW 1/15/2021259,300 shares $799,940.50 +2.6%N/A46.3 $3.09 12/31/2020252,300 shares $761,946.00 -2.7%N/A45.9 $3.02 12/15/2020259,300 shares $785,679.00 +2.6%N/A46.3 $3.03 11/30/2020252,800 shares $793,792.00 +19.4%N/A57.5 $3.14 11/15/2020211,800 shares $677,760.00 -68.7%N/A13.1 $3.20 10/30/2020677,300 shares $2.42 million +38.4%N/A376.3 $3.58 10/15/2020489,300 shares $1.74 million +38.4%N/A181.2 $3.55 9/30/2020353,600 shares $1.58 million +3.2%N/A589.3 $4.47 SPHDF Short Interest - Frequently Asked Questions What is Santhera Pharmaceuticals' current short interest? Short interest is the volume of Santhera Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of November 30th, investors have sold 100 shares of SPHDF short. Learn More on Santhera Pharmaceuticals' current short interest. Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.70 billion), Charter Communications, Inc. ($4.55 billion), Spotify Technology S.A. ($3.84 billion), Royal Caribbean Cruises Ltd. ($3.07 billion), International Paper ($3.00 billion), Coinbase Global, Inc. ($2.93 billion), Cencora, Inc. ($2.54 billion), Paychex, Inc. ($2.53 billion), SoFi Technologies, Inc. ($2.24 billion), and Reddit, Inc. ($2.00 billion). View all of the most shorted stocks. What does it mean to sell short Santhera Pharmaceuticals stock? Short selling SPHDF is an investing strategy that aims to generate trading profit from Santhera Pharmaceuticals as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Santhera Pharmaceuticals? A short squeeze for Santhera Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of SPHDF, which in turn drives the price of the stock up even further. How often is Santhera Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SPHDF, twice per month. The most recent reporting period available is November, 30 2024. More Short Interest Resources from MarketBeat Related Companies ATNFW Short Interest Data TRSBF Short Interest Data AGTX Short Interest Data AGNPF Short Interest Data DRTSW Short Interest Data WENAW Short Interest Data APLMW Short Interest Data ASPHF Short Interest Data ASCLF Short Interest Data AVCTF Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:SPHDF) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Santhera Pharmaceuticals Holding AG Please log in to your account or sign up in order to add this asset to your watchlist. Share Santhera Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
